• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因组改变作为卵巢癌中微小RNA失调的介质

Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.

作者信息

Kan Casina W S, Howell Viive M, Hahn Michael A, Marsh Deborah J

机构信息

Hormones and Cancer Group, Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, St Leonards, Sydney, NSW 2065, Australia.

出版信息

Genes Chromosomes Cancer. 2015 Jan;54(1):1-19. doi: 10.1002/gcc.22221. Epub 2014 Oct 3.

DOI:10.1002/gcc.22221
PMID:25280227
Abstract

Ovarian cancer is the fifth most common cause of cancer death in women worldwide. Serous epithelial ovarian cancer (SEOC) is the most common and aggressive histological subtype. Widespread genomic alterations go hand-in-hand with aberrant DNA damage signaling and are a hallmark of high-grade SEOC. MicroRNAs (miRNAs) are a class of small noncoding RNA molecules that are nonrandomly distributed in the genome. They are frequently located in chromosomal regions susceptible to copy number variation (CNV) associated with malignancy that can influence their expression. Widespread changes in miRNA expression have been reported in multiple cancer types including ovarian cancer. This review examines CNV and single nucleotide polymorphisms, two common types of genomic alterations that occur in ovarian cancer, in the context of their influence on the expression of miRNA and the ability of miRNA to bind to and regulate their target genes. This includes genes encoding proteins involved in DNA repair and the maintenance of genomic stability. Improved understanding of mechanisms of miRNA dysregulation and the role of miRNA in ovarian cancer will provide further insight into the pathogenesis and treatment of this disease.

摘要

卵巢癌是全球女性癌症死亡的第五大常见原因。浆液性上皮性卵巢癌(SEOC)是最常见且侵袭性最强的组织学亚型。广泛的基因组改变与异常的DNA损伤信号传导相伴,是高级别SEOC的一个标志。微小RNA(miRNA)是一类小的非编码RNA分子,它们在基因组中呈非随机分布。它们经常位于与恶性肿瘤相关的易发生拷贝数变异(CNV)的染色体区域,而这种变异会影响它们的表达。在包括卵巢癌在内的多种癌症类型中,均已报道了miRNA表达的广泛变化。本综述在基因组改变对miRNA表达的影响以及miRNA与靶基因结合并调控靶基因能力的背景下,研究了拷贝数变异(CNV)和单核苷酸多态性这两种在卵巢癌中发生的常见基因组改变类型。这包括编码参与DNA修复和维持基因组稳定性的蛋白质的基因。对miRNA失调机制以及miRNA在卵巢癌中作用的深入了解,将为该疾病的发病机制和治疗提供进一步的见解。

相似文献

1
Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.基因组改变作为卵巢癌中微小RNA失调的介质
Genes Chromosomes Cancer. 2015 Jan;54(1):1-19. doi: 10.1002/gcc.22221. Epub 2014 Oct 3.
2
MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.微小RNA-200c和微小RNA-31调节浆液性卵巢癌的增殖、集落形成、迁移和侵袭。
J Ovarian Res. 2015 Aug 12;8:56. doi: 10.1186/s13048-015-0186-7.
3
Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.卵巢癌中异常甲基化调控的新型 miRNA 基因参与转移。
Gene. 2018 Jul 1;662:28-36. doi: 10.1016/j.gene.2018.04.005. Epub 2018 Apr 6.
4
MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.微小RNA-145靶向TRIM2并在上皮性卵巢癌中发挥肿瘤抑制功能。
Gynecol Oncol. 2015 Dec;139(3):513-9. doi: 10.1016/j.ygyno.2015.10.008. Epub 2015 Oct 16.
5
Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer.神经生长因子(NGF)和微小RNA(miRNAs)在上皮性卵巢癌中的作用
Int J Mol Sci. 2017 Feb 26;18(3):507. doi: 10.3390/ijms18030507.
6
MiRNA-210: A Current Overview.微小RNA-210:当前概述
Anticancer Res. 2017 Dec;37(12):6511-6521. doi: 10.21873/anticanres.12107.
7
POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.POSTN/TGFBI 相关的基质特征可预测浆液性上皮性卵巢癌的不良预后。
Gynecol Oncol. 2014 Feb;132(2):334-42. doi: 10.1016/j.ygyno.2013.12.021. Epub 2013 Dec 22.
8
A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.循环微小RNA-125b作为上皮性卵巢癌诊断和预后生物标志物的初步研究
Int J Gynecol Cancer. 2017 Jan;27(1):3-10. doi: 10.1097/IGC.0000000000000846.
9
Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer.靶向基因和表观遗传改变治疗浆液性卵巢癌。
Cancer Genet. 2011 Oct;204(10):525-35. doi: 10.1016/j.cancergen.2011.09.004.
10
Suppression of SIK1 by miR-141 in human ovarian cancer cell lines and tissues.miR-141 抑制人卵巢癌细胞系和组织中的 SIK1 表达。
Int J Mol Med. 2016 Jun;37(6):1601-10. doi: 10.3892/ijmm.2016.2553. Epub 2016 Apr 11.

引用本文的文献

1
miRNA on the Battlefield of Cancer: Significance in Cancer Stem Cells, WNT Pathway, and Treatment.癌症战场上的微小RNA:在癌症干细胞、WNT信号通路及治疗中的意义
Cancers (Basel). 2024 Feb 27;16(5):957. doi: 10.3390/cancers16050957.
2
MiR-5590-3p inhibits the proliferation and invasion of ovarian cancer cells through mediating the Wnt/β-catenin signaling pathway by targeting TNIK.miR-5590-3p 通过靶向 TNIK 介导的 Wnt/β-连环蛋白信号通路抑制卵巢癌细胞的增殖和侵袭。
Histol Histopathol. 2024 Mar;39(3):345-355. doi: 10.14670/HH-18-636. Epub 2023 Jun 5.
3
Relationship between NUDT21 mediated alternative polyadenylation process and tumor.
NUDT21介导的可变聚腺苷酸化过程与肿瘤之间的关系。
Front Oncol. 2023 Feb 2;13:1052012. doi: 10.3389/fonc.2023.1052012. eCollection 2023.
4
Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.卵巢癌中失调的miRNA簇:对个性化医疗的重要意义。
Genes Dis. 2022 Mar 1;9(6):1443-1465. doi: 10.1016/j.gendis.2021.12.026. eCollection 2022 Nov.
5
MicroRNA-378a-3p contributes to ovarian cancer progression through downregulating PDIA4.miRNA-378a-3p 通过下调 PDIA4 促进卵巢癌进展。
Immun Inflamm Dis. 2021 Mar;9(1):108-119. doi: 10.1002/iid3.350. Epub 2020 Nov 7.
6
Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.循环 microRNAs 作为卵巢癌新型潜在诊断生物标志物的系统评价和更新荟萃分析。
J Ovarian Res. 2019 Mar 21;12(1):24. doi: 10.1186/s13048-019-0482-8.
7
Identification and Characterization of MicroRNAs Associated with Somatic Copy Number Alterations in Cancer.与癌症体细胞拷贝数改变相关的微小RNA的鉴定与特征分析
Cancers (Basel). 2018 Nov 29;10(12):475. doi: 10.3390/cancers10120475.
8
rs642321 Polymorphism Influence Susceptibility to Childhood Acute Lymphoblastic Leukemia: A Preliminary Report.rs642321多态性对儿童急性淋巴细胞白血病易感性的影响:初步报告。
Indian J Med Paediatr Oncol. 2017 Oct-Dec;38(4):416-419. doi: 10.4103/ijmpo.ijmpo_4_15.
9
Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer.古今中外:提示一个核心转录后网络驱动卵巢癌化疗耐药。
Wiley Interdiscip Rev RNA. 2018 Jan;9(1). doi: 10.1002/wrna.1432. Epub 2017 Aug 1.
10
Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression.基因组失衡与卵巢肿瘤中miR-30c和let-7a的失调有关:对HMGA2表达的影响。
Oncotarget. 2017 Mar 28;8(13):21554-21560. doi: 10.18632/oncotarget.15795.